Belite Bio

BLTENasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$6.414 B

$163.05 +1.48%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$77.6M

Loss-making

Shares outstanding

39,339,960

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#47Cogent BiosciencesCOGT$7.24B
#48Mirum PharmaceuticalsMIRM$6.54B
#49Belite BioBLTE$6.41B
#50ErascaERAS$6.30B
#51Xenon PharmaceuticalsXENE$6.12B

Where these numbers come from

Share counts and financials for Belite Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.